-
Sarepta Therapeutics' (SRPT) Overweight Rating Reiterated at Cantor Fitzgerald
来源: Buzz FX / 19 3月 2025 09:46:18 America/New_York
Sarepta Therapeutics' (SRPT) Overweight Rating Reiterated at Cantor Fitzgerald Written by MarketBeat March 19, 2025 Share Link copied to clipboard. Remove Ads Sarepta Therapeutics ( NASDAQ:SRPT - Get Free Report ) 's stock had its "overweig
Read more...